Download PDF
Semin Thromb Hemost 2015; 41(03): 300-314
DOI: 10.1055/s-0035-1549089
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

The Influence of Herbal Medicine on Platelet Function and Coagulation: A Narrative Review

Bradley J. McEwen
1   Department of Naturopathic Medicine, Endeavour College of Natural Health, Sydney, New South Wales, Australia
› Author Affiliations
Further Information

Publication History

Publication Date:
03 April 2015 (online)

    Permissions and Reprints

Abstract

Cardiovascular disease (CVD) is the leading cause of death worldwide. Platelet activation and aggregation play a central role in hemostasis and thrombosis. Herbal medicines have been traditionally used in the management of CVD and can play a role in modifying CVD progression, particularly in platelet function, and have the potential of altering platelet function tests, as well as some coagulation parameters. Herbal medicines, such as feverfew, garlic, ginger, ginseng, motherwort, St John's wort, and willow bark, were found to reduce platelet aggregation. In vitro studies show promise in the reduction of platelet aggregation for Andrographis, feverfew, garlic, ginger, Ginkgo, ginseng, hawthorn, horse chestnut, and turmeric. In addition, cranberry, danshen, dong quai, Ginkgo, ginseng, green tea, and St John's wort were found to have potential interactions with warfarin. Furthermore, St John's wort interacted with clopidogrel and danshen with aspirin. Therefore, repeat testing of platelet function and coagulation studies, particularly for patients on warfarin therapy, may be required after exclusion of herbal medicines that could have possibly affected initial test results.

Keywords

cardiovascular disease - platelet aggregation - platelet function - herbal medicine - warfarin
 

  • References

  • 1 Go AS, Mozaffarian D, Roger VL , et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation 2014; 129 (3) e28-e292
    CrossrefPubMedSearch in Google Scholar
  • 2 Ruggeri ZM. Platelets in atherothrombosis. Nat Med 2002; 8 (11) 1227-1234
    CrossrefPubMedSearch in Google Scholar
  • 3 Koenig W. Haemostatic risk factors for cardiovascular diseases. Eur Heart J 1998; 19 (Suppl C): C39-C43
    PubMedSearch in Google Scholar
  • 4 Mozaffarian D, Benjamin EJ, Go AS , et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation 2015; 131 (4) e29-e322
    CrossrefPubMedSearch in Google Scholar
  • 5 Lorenzet R, Napoleone E, Cutrone A, Donati MB. Thrombosis and obesity: cellular bases. Thromb Res 2012; 129 (3) 285-289
    CrossrefPubMedSearch in Google Scholar
  • 6 Versteeg HH, Heemskerk JW, Levi M, Reitsma PH. New fundamentals in hemostasis. Physiol Rev 2013; 93 (1) 327-358
    CrossrefPubMedSearch in Google Scholar
  • 7 Davì G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007; 357 (24) 2482-2494
    CrossrefPubMedSearch in Google Scholar
  • 8 Fontana P, Zufferey A, Daali Y, Reny JL. Antiplatelet therapy: targeting the TxA2 pathway. J Cardiovasc Transl Res 2014; 7 (1) 29-38
    CrossrefPubMedSearch in Google Scholar
  • 9 Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med 2008; 359 (9) 938-949
    CrossrefPubMedSearch in Google Scholar
  • 10 Riccioni G, Sblendorio V. Atherosclerosis: from biology to pharmacological treatment. J Geriatr Cardiol 2012; 9 (3) 305-317
    PubMedSearch in Google Scholar
  • 11 Projahn D, Koenen RR. Platelets: key players in vascular inflammation. J Leukoc Biol 2012; 92 (6) 1167-1175
    CrossrefPubMedSearch in Google Scholar
  • 12 Shantsila E, Lip GY. The role of monocytes in thrombotic disorders. Insights from tissue factor, monocyte-platelet aggregates and novel mechanisms. Thromb Haemost 2009; 102 (5) 916-924
    PubMedSearch in Google Scholar
  • 13 Danese E, Montagnana M, Cervellin G, Lippi G. Hypercoagulability, D-dimer and atrial fibrillation: an overview of biological and clinical evidence. Ann Med 2014; 46 (6) 364-371
    CrossrefPubMedSearch in Google Scholar
  • 14 Lippi G, Franchini M. Pathogenesis of venous thromboembolism: when the cup runneth over. Semin Thromb Hemost 2008; 34 (8) 747-761
    Thieme ConnectPubMedSearch in Google Scholar
  • 15 Harrison P, Mumford A. Screening tests of platelet function: update on their appropriate uses for diagnostic testing. Semin Thromb Hemost 2009; 35 (2) 150-157
    Thieme ConnectPubMedSearch in Google Scholar
  • 16 Michelson AD. Methods for the measurement of platelet function. Am J Cardiol 2009; 103 (3, Suppl): 20A-26A
    CrossrefPubMedSearch in Google Scholar
  • 17 Born GV. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927-929
    PubMedSearch in Google Scholar
  • 18 Cattaneo M. Light transmission aggregometry and ATP release for the diagnostic assessment of platelet function. Semin Thromb Hemost 2009; 35 (2) 158-167
    Thieme ConnectPubMedSearch in Google Scholar
  • 19 Favaloro EJ, Lippi G, Franchini M. Contemporary platelet function testing. Clin Chem Lab Med 2010; 48 (5) 579-598
    CrossrefPubMedSearch in Google Scholar
  • 20 Michelson AD. Flow cytometry: a clinical test of platelet function. Blood 1996; 87 (12) 4925-4936
    PubMedSearch in Google Scholar
  • 21 Favaloro EJ. Clinical utility of the PFA-100. Semin Thromb Hemost 2008; 34 (8) 709-733
    Thieme ConnectPubMedSearch in Google Scholar
  • 22 Patrono C, Rocca B. Aspirin: promise and resistance in the new millennium. Arterioscler Thromb Vasc Biol 2008; 28 (3) s25-s32
    CrossrefPubMedSearch in Google Scholar
  • 23 Morgan G. The established and emerging uses of aspirin. Basic Clin Pharmacol Toxicol 2006; 99 (4) 283-286
    CrossrefPubMedSearch in Google Scholar
  • 24 Martínez-Quintana E, Tugores A. Clopidogrel: a multifaceted affair. J Clin Pharmacol 2015; 55 (1) 1-9
    CrossrefPubMedSearch in Google Scholar
  • 25 Karaźniewicz-Łada M, Danielak D, Burchardt P , et al. Clinical pharmacokinetics of clopidogrel and its metabolites in patients with cardiovascular diseases. Clin Pharmacokinet 2014; 53 (2) 155-164
    CrossrefPubMedSearch in Google Scholar
  • 26 Wadhera RK, Russell CE, Piazza G. Cardiology patient page. Warfarin versus novel oral anticoagulants: how to choose?. Circulation 2014; 130 (22) e191-e193
    CrossrefPubMedSearch in Google Scholar
  • 27 Hamann GL, Campbell JD, George CM. Warfarin-cranberry juice interaction. Ann Pharmacother 2011; 45 (3) e17
    CrossrefPubMedSearch in Google Scholar
  • 28 Winslow LC, Kroll DJ. Herbs as medicines. Arch Intern Med 1998; 158 (20) 2192-2199
    CrossrefPubMedSearch in Google Scholar
  • 29 Mashour NH, Lin GI, Frishman WH. Herbal medicine for the treatment of cardiovascular disease: clinical considerations. Arch Intern Med 1998; 158 (20) 2225-2234
    CrossrefPubMedSearch in Google Scholar
  • 30 McEwen BJ. The influence of diet and nutrients on platelet function. Semin Thromb Hemost 2014; 40 (2) 214-226
    Thieme ConnectPubMedSearch in Google Scholar
  • 31 Lu WJ, Lin KH, Hsu MJ, Chou DS, Hsiao G, Sheu JR. Suppression of NF-κB signaling by andrographolide with a novel mechanism in human platelets: regulatory roles of the p38 MAPK-hydroxyl radical-ERK2 cascade. Biochem Pharmacol 2012; 84 (7) 914-924
    CrossrefPubMedSearch in Google Scholar
  • 32 Thisoda P, Rangkadilok N, Pholphana N, Worasuttayangkurn L, Ruchirawat S, Satayavivad J. Inhibitory effect of Andrographis paniculata extract and its active diterpenoids on platelet aggregation. Eur J Pharmacol 2006; 553 (1-3) 39-45
    CrossrefPubMedSearch in Google Scholar
  • 33 Amroyan E, Gabrielian E, Panossian A, Wikman G, Wagner H. Inhibitory effect of andrographolide from Andrographis paniculata on PAF-induced platelet aggregation. Phytomedicine 1999; 6 (1) 27-31
    CrossrefPubMedSearch in Google Scholar
  • 34 Mohammed Abdul MI, Jiang X, Williams KM , et al. Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects. Br J Pharmacol 2008; 154 (8) 1691-1700
    PubMedSearch in Google Scholar
  • 35 Zhou L, Wang S, Zhang Z , et al. Pharmacokinetic and pharmacodynamic interaction of Danshen-Gegen extract with warfarin and aspirin. J Ethnopharmacol 2012; 143 (2) 648-655
    CrossrefPubMedSearch in Google Scholar
  • 36 Chan K, Lo AC, Yeung JH, Woo KS. The effects of Danshen (Salvia miltiorrhiza) on warfarin pharmacodynamics and pharmacokinetics of warfarin enantiomers in rats. J Pharm Pharmacol 1995; 47 (5) 402-406
    CrossrefPubMedSearch in Google Scholar
  • 37 Dong WG, Liu SP, Zhu HH, Luo HS, Yu JP. Abnormal function of platelets and role of angelica sinensis in patients with ulcerative colitis. World J Gastroenterol 2004; 10 (4) 606-609
    CrossrefPubMedSearch in Google Scholar
  • 38 Page II RL, Lawrence JD. Potentiation of warfarin by dong quai. Pharmacotherapy 1999; 19 (7) 870-876
    CrossrefPubMedSearch in Google Scholar
  • 39 Groenewegen WA, Heptinstall S. A comparison of the effects of an extract of feverfew and parthenolide, a component of feverfew, on human platelet activity in-vitro. J Pharm Pharmacol 1990; 42 (8) 553-557
    CrossrefPubMedSearch in Google Scholar
  • 40 Biggs MJ, Johnson ES, Persaud NP, Ratcliffe DM. Platelet aggregation in patients using feverfew for migraine. Lancet 1982; 2 (8301) 776
    PubMedSearch in Google Scholar
  • 41 Sahler J, Bernard JJ, Spinelli SL, Blumberg N, Phipps RP. The feverfew plant-derived compound, parthenolide enhances platelet production and attenuates platelet activation through NF-κB inhibition. Thromb Res 2011; 127 (5) 426-434
    CrossrefPubMedSearch in Google Scholar
  • 42 Bordia A, Verma SK, Srivastava KC. Effect of garlic on platelet aggregation in humans: a study in healthy subjects and patients with coronary artery disease. Prostaglandins Leukot Essent Fatty Acids 1996; 55 (3) 201-205
    CrossrefPubMedSearch in Google Scholar
  • 43 Rahman K, Billington D. Dietary supplementation with aged garlic extract inhibits ADP-induced platelet aggregation in humans. J Nutr 2000; 130 (11) 2662-2665
    PubMedSearch in Google Scholar
  • 44 Allison GL, Lowe GM, Rahman K. Aged garlic extract may inhibit aggregation in human platelets by suppressing calcium mobilization. J Nutr 2006; 136 (3, Suppl): 789S-792S
    PubMedSearch in Google Scholar
  • 45 Steiner M, Lin RS. Changes in platelet function and susceptibility of lipoproteins to oxidation associated with administration of aged garlic extract. J Cardiovasc Pharmacol 1998; 31 (6) 904-908
    CrossrefPubMedSearch in Google Scholar
  • 46 Wojcikowski K, Myers S, Brooks L. Effects of garlic oil on platelet aggregation: a double-blind placebo-controlled crossover study. Platelets 2007; 18 (1) 29-34
    CrossrefPubMedSearch in Google Scholar
  • 47 Bordia A, Verma SK, Srivastava KC. Effect of ginger (Zingiber officinale Rosc.) and fenugreek (Trigonella foenumgraecum L.) on blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease. Prostaglandins Leukot Essent Fatty Acids 1997; 56 (5) 379-384
    CrossrefPubMedSearch in Google Scholar
  • 48 Nurtjahja-Tjendraputra E, Ammit AJ, Roufogalis BD, Tran VH, Duke CC. Effective anti-platelet and COX-1 enzyme inhibitors from pungent constituents of ginger. Thromb Res 2003; 111 (4-5) 259-265
    CrossrefPubMedSearch in Google Scholar
  • 49 Lamant V, Mauco G, Braquet P, Chap H, Douste-Blazy L. Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from Ginkgo biloba. Biochem Pharmacol 1987; 36 (17) 2749-2752
    CrossrefPubMedSearch in Google Scholar
  • 50 Koch E. Inhibition of platelet activating factor (PAF)-induced aggregation of human thrombocytes by ginkgolides: considerations on possible bleeding complications after oral intake of Ginkgo biloba extracts. Phytomedicine 2005; 12 (1-2) 10-16
    CrossrefPubMedSearch in Google Scholar
  • 51 Jin YR, Yu JY, Lee JJ , et al. Antithrombotic and antiplatelet activities of Korean red ginseng extract. Basic Clin Pharmacol Toxicol 2007; 100 (3) 170-175
    CrossrefPubMedSearch in Google Scholar
  • 52 Lee SH, Ahn YM, Ahn SY, Doo HK, Lee BC. Interaction between warfarin and Panax ginseng in ischemic stroke patients. J Altern Complement Med 2008; 14 (6) 715-721
    CrossrefPubMedSearch in Google Scholar
  • 53 Yuan CS, Wei G, Dey L , et al. Brief communication: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled trial. Ann Intern Med 2004; 141 (1) 23-27
    CrossrefPubMedSearch in Google Scholar
  • 54 Zhou Q, Jiang L, Xu C , et al. Ginsenoside Rg1 inhibits platelet activation and arterial thrombosis. Thromb Res 2014; 133 (1) 57-65
    CrossrefPubMedSearch in Google Scholar
  • 55 Lau AJ, Toh DF, Chua TK, Pang YK, Woo SO, Koh HL. Antiplatelet and anticoagulant effects of Panax notoginseng: comparison of raw and steamed Panax notoginseng with Panax ginseng and Panax quinquefolium. J Ethnopharmacol 2009; 125 (3) 380-386
    CrossrefPubMedSearch in Google Scholar
  • 56 Iida Y, Doi T, Matsushima-Nishiwaki R , et al. (-)-Epigallocatechin gallate selectively inhibits adenosine diphosphate‑stimulated human platelet activation: suppression of heat shock protein 27 phosphorylation via p38 mitogen‑activated protein kinase. Mol Med Rep 2014; 10 (3) 1383-1388
    PubMedSearch in Google Scholar
  • 57 Son DJ, Cho MR, Jin YR , et al. Antiplatelet effect of green tea catechins: a possible mechanism through arachidonic acid pathway. Prostaglandins Leukot Essent Fatty Acids 2004; 71 (1) 25-31
    CrossrefPubMedSearch in Google Scholar
  • 58 Rogers KL, Grice ID, Griffiths LR. Inhibition of platelet aggregation and 5-HT release by extracts of Australian plants used traditionally as headache treatments. Eur J Pharm Sci 2000; 9 (4) 355-363
    CrossrefPubMedSearch in Google Scholar
  • 59 Vibes J, Lasserre B, Gleye J, Declume C. Inhibition of thromboxane A2 biosynthesis in vitro by the main components of Crataegus oxyacantha (hawthorn) flower heads. Prostaglandins Leukot Essent Fatty Acids 1994; 50 (4) 173-175
    CrossrefPubMedSearch in Google Scholar
  • 60 Xiong L, Zhou QM, Peng C , et al. Bis-spirolabdane diterpenoids from Leonurus japonicus and their anti-platelet aggregative activity. Fitoterapia 2015; 100: 1-6
    CrossrefPubMedSearch in Google Scholar
  • 61 Xiong L, Zhou QM, Peng C , et al. Sesquiterpenoids from the herb of Leonurus japonicus. Molecules 2013; 18 (5) 5051-5058
    CrossrefPubMedSearch in Google Scholar
  • 62 Lau WC, Welch TD, Shields T, Rubenfire M, Tantry US, Gurbel PA. The effect of St John's wort on the pharmacodynamic response of clopidogrel in hyporesponsive volunteers and patients: increased platelet inhibition by enhancement of CYP3A4 metabolic activity. J Cardiovasc Pharmacol 2011; 57 (1) 86-93
    CrossrefPubMedSearch in Google Scholar
  • 63 Yue QY, Bergquist C, Gerdén B. Safety of St John's wort (Hypericum perforatum). Lancet 2000; 355 (9203) 576-577
    CrossrefPubMedSearch in Google Scholar
  • 64 Shah BH, Nawaz Z, Pertani SA , et al. Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor- and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signaling. Biochem Pharmacol 1999; 58 (7) 1167-1172
    CrossrefPubMedSearch in Google Scholar
  • 65 Srivastava KC, Bordia A, Verma SK. Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets. Prostaglandins Leukot Essent Fatty Acids 1995; 52 (4) 223-227
    CrossrefPubMedSearch in Google Scholar
  • 66 Mayanglambam A, Dangelmaier CA, Thomas D, Damodar Reddy C, Daniel JL, Kunapuli SP. Curcumin inhibits GPVI-mediated platelet activation by interfering with the kinase activity of Syk and the subsequent activation of PLCgamma2. Platelets 2010; 21 (3) 211-220
    CrossrefPubMedSearch in Google Scholar
  • 67 Krivoy N, Pavlotzky E, Chrubasik S, Eisenberg E, Brook G. Effect of salicis cortex extract on human platelet aggregation. Planta Med 2001; 67 (3) 209-212
    Thieme ConnectPubMedSearch in Google Scholar
  • 68 Craig WJ. Health-promoting properties of common herbs. Am J Clin Nutr 1999; 70 (3, Suppl): 491S-499S
    PubMedSearch in Google Scholar
  • 69 Vickers A, Zollman C. ABC of complementary medicine: herbal medicine. BMJ 1999; 319 (7216) 1050-1053
    PubMedSearch in Google Scholar
  • 70 Yeh GY, Davis RB, Phillips RS. Use of complementary therapies in patients with cardiovascular disease. Am J Cardiol 2006; 98 (5) 673-680
    CrossrefPubMedSearch in Google Scholar
  • 71 Wood MJ, Stewart RL, Merry H, Johnstone DE, Cox JL. Use of complementary and alternative medical therapies in patients with cardiovascular disease. Am Heart J 2003; 145 (5) 806-812
    CrossrefPubMedSearch in Google Scholar
  • 72 Chen XW, Sneed KB, Pan SY , et al. Herb-drug interactions and mechanistic and clinical considerations. Curr Drug Metab 2012; 13 (5) 640-651
    CrossrefPubMedSearch in Google Scholar
  • 73 Blumberg JB, Camesano TA, Cassidy A , et al. Cranberries and their bioactive constituents in human health. Adv Nutr 2013; 4 (6) 618-632
    CrossrefPubMedSearch in Google Scholar
  • 74 McKay DL, Blumberg JB. Cranberries (Vaccinium macrocarpon) and cardiovascular disease risk factors. Nutr Rev 2007; 65 (11) 490-502
    CrossrefPubMedSearch in Google Scholar
  • 75 Mellen CK, Ford M, Rindone JP. Effect of high-dose cranberry juice on the pharmacodynamics of warfarin in patients. Br J Clin Pharmacol 2010; 70 (1) 139-142
    CrossrefPubMedSearch in Google Scholar
  • 76 Yu CM, Chan JC, Sanderson JE. Chinese herbs and warfarin potentiation by ‘danshen’. J Intern Med 1997; 241 (4) 337-339
    CrossrefPubMedSearch in Google Scholar
  • 77 Cheng TO. Cardiovascular effects of Danshen. Int J Cardiol 2007; 121 (1) 9-22
    CrossrefPubMedSearch in Google Scholar
  • 78 Izzat MB, Yim AP, El-Zufari MH. A taste of Chinese medicine!. Ann Thorac Surg 1998; 66 (3) 941-942
    CrossrefPubMedSearch in Google Scholar
  • 79 Pareek A, Suthar M, Rathore GS, Bansal V. Feverfew (Tanacetum parthenium L.): a systematic review. Pharmacogn Rev 2011; 5 (9) 103-110
    CrossrefPubMedSearch in Google Scholar
  • 80 Khatua TN, Adela R, Banerjee SK. Garlic and cardioprotection: insights into the molecular mechanisms. Can J Physiol Pharmacol 2013; 91 (6) 448-458
    CrossrefPubMedSearch in Google Scholar
  • 81 Rahman K, Lowe GM. Garlic and cardiovascular disease: a critical review. J Nutr 2006; 136 (3, Suppl): 736S-740S
    PubMedSearch in Google Scholar
  • 82 Foster BC, Foster MS, Vandenhoek S , et al. An in vitro evaluation of human cytochrome P450 3A4 and P-glycoprotein inhibition by garlic. J Pharm Pharm Sci 2001; 4 (2) 176-184
    PubMedSearch in Google Scholar
  • 83 Bartels EM, Folmer VN, Bliddal H , et al. Efficacy and safety of ginger in osteoarthritis patients: a meta-analysis of randomized placebo-controlled trials. Osteoarthritis Cartilage 2015; 23 (1) 13-21
    CrossrefPubMedSearch in Google Scholar
  • 84 Jiang X, Williams KM, Liauw WS , et al. Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol 2005; 59 (4) 425-432
    CrossrefPubMedSearch in Google Scholar
  • 85 Heinonen T, Gaus W. Cross matching observations on toxicological and clinical data for the assessment of tolerability and safety of Ginkgo biloba leaf extract. Toxicology 2015; 327C: 95-115
    PubMedSearch in Google Scholar
  • 86 Kudolo GB, Dorsey S, Blodgett J. Effect of the ingestion of Ginkgo biloba extract on platelet aggregation and urinary prostanoid excretion in healthy and Type 2 diabetic subjects. Thromb Res 2002; 108 (2-3) 151-160
    CrossrefPubMedSearch in Google Scholar
  • 87 Jung F, Mrowietz C, Kiesewetter H, Wenzel E. Effect of Ginkgo biloba on fluidity of blood and peripheral microcirculation in volunteers. Arzneimittelforschung 1990; 40 (5) 589-593
    PubMedSearch in Google Scholar
  • 88 Gardner CD, Zehnder JL, Rigby AJ, Nicholus JR, Farquhar JW. Effect of Ginkgo biloba (EGb 761) and aspirin on platelet aggregation and platelet function analysis among older adults at risk of cardiovascular disease: a randomized clinical trial. Blood Coagul Fibrinolysis 2007; 18 (8) 787-793
    CrossrefPubMedSearch in Google Scholar
  • 89 Lee CH, Kim JH. A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases. J Ginseng Res 2014; 38 (3) 161-166
    CrossrefPubMedSearch in Google Scholar
  • 90 Thielecke F, Boschmann M. The potential role of green tea catechins in the prevention of the metabolic syndrome - a review. Phytochemistry 2009; 70 (1) 11-24
    CrossrefPubMedSearch in Google Scholar
  • 91 Yousaf S, Butt MS, Suleria HA, Iqbal MJ. The role of green tea extract and powder in mitigating metabolic syndromes with special reference to hyperglycemia and hypercholesterolemia. Food Funct 2014; 5 (3) 545-556
    CrossrefPubMedSearch in Google Scholar
  • 92 Cheng TO. Green tea may inhibit warfarin. Int J Cardiol 2007; 115 (2) 236
    CrossrefPubMedSearch in Google Scholar
  • 93 Wang J, Xiong X, Feng B. Effect of Crataegus usage in cardiovascular disease prevention: an evidence-based approach. Evid Based Complement Alternat Med 2013; 2013: 149363
    PubMedSearch in Google Scholar
  • 94 Brenyo A, Aktas MK. Review of complementary and alternative medical treatment of arrhythmias. Am J Cardiol 2014; 113 (5) 897-903
    CrossrefPubMedSearch in Google Scholar
  • 95 Felixsson E, Persson IA, Eriksson AC, Persson K. Horse chestnut extract contracts bovine vessels and affects human platelet aggregation through 5-HT(2A) receptors: an in vitro study. Phytother Res 2010; 24 (9) 1297-1301
    CrossrefPubMedSearch in Google Scholar
  • 96 Pittler MH, Ernst E. Horse chestnut seed extract for chronic venous insufficiency. Cochrane Database Syst Rev 2012; 11: CD003230
    PubMedSearch in Google Scholar
  • 97 Sirtori CR. Aescin: pharmacology, pharmacokinetics and therapeutic profile. Pharmacol Res 2001; 44 (3) 183-193
    CrossrefPubMedSearch in Google Scholar
  • 98 Shang X, Pan H, Wang X, He H, Li M. Leonurus japonicus Houtt.: ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine. J Ethnopharmacol 2014; 152 (1) 14-32
    CrossrefPubMedSearch in Google Scholar
  • 99 Zou QZ, Bi RG, Li JM , et al. Effect of motherwort on blood hyperviscosity. Am J Chin Med 1989; 17 (1-2) 65-70
    CrossrefPubMedSearch in Google Scholar
  • 100 Russo E, Scicchitano F, Whalley BJ , et al. Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions. Phytother Res 2014; 28 (5) 643-655
    CrossrefPubMedSearch in Google Scholar
  • 101 Obach RS. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression. J Pharmacol Exp Ther 2000; 294 (1) 88-95
    PubMedSearch in Google Scholar
  • 102 Prasad S, Gupta SC, Tyagi AK, Aggarwal BB. Curcumin, a component of golden spice: from bedside to bench and back. Biotechnol Adv 2014; 32 (6) 1053-1064
    CrossrefPubMedSearch in Google Scholar
  • 103 Aggarwal BB, Sundaram C, Malani N, Ichikawa H. Curcumin: the Indian solid gold. Adv Exp Med Biol 2007; 595: 1-75
    PubMedSearch in Google Scholar
  • 104 Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci 2008; 65 (11) 1631-1652
    CrossrefPubMedSearch in Google Scholar
  • 105 Menon VP, Sudheer AR. Antioxidant and anti-inflammatory properties of curcumin. Adv Exp Med Biol 2007; 595: 105-125
    PubMedSearch in Google Scholar
  • 106 Schmid B, Lüdtke R, Selbmann HK , et al. Efficacy and tolerability of a standardized willow bark extract in patients with osteoarthritis: randomized placebo-controlled, double blind clinical trial. Phytother Res 2001; 15 (4) 344-350
    CrossrefPubMedSearch in Google Scholar
  • 107 Vainio H, Morgan G. Aspirin for the second hundred years: new uses for an old drug. Pharmacol Toxicol 1997; 81 (4) 151-152
    CrossrefPubMedSearch in Google Scholar
  • 108 Lippi G, Favaloro EJ. Recent guidelines and recommendations for laboratory assessment of the direct oral anticoagulants (DOACs): is there consensus?. Clin Chem Lab Med 2015; 53 (2) 185-197
    PubMedSearch in Google Scholar
  • 109 Lippi G, Favaloro EJ, Mattiuzzi C. Combined administration of antibiotics and direct oral anticoagulants: a renewed indication for laboratory monitoring?. Semin Thromb Hemost 2014; 40 (7) 756-765
    Thieme ConnectPubMedSearch in Google Scholar